Niemann-Pick C1 Mice, a Model of “Juvenile Alzheimer's Disease”, with Normal Gene Expression in Neurons and Fibrillary Astrocytes Show Long Term Survival and Delayed Neurodegeneration
Affiliations: [a] Department of Pediatrics, University of Arizona, Tucson, AZ, USA | [b] Departments of Biomedical Engineering, University of Arizona, Tucson, AZ, USA | [c] Department of Psychology, Section of Neuroscience, Pasteur Institute-Cenci Bolognetti Foundation and “Daniel Bovet” Neurobiology Research Center, Sapienza University of Rome, Rome, Italy | [d] Department of Molecular and Cellular Biology, University of Arizona, Tucson, AZ, USA
Correspondence:
[*]
Correspondence to: Robert P. Erickson, Department of Pediatrics, University of Arizona, Health Science Center, Tucson, AZ 85724-5073, USA. Tel.: +1 5206262314; Fax: +1 5206267407; E-mail: [email protected].
Abstract: Niemann-Pick C1 (NPC) disease, also known as “juvenile Alzheimer's disease”, is a disease in which alterations in intracellular cholesterol trafficking occur. The contribution of various CNS cell types to the neurodegeneration has been of much interest. We have previously shown that expression of the normal gene only in fibrillary astrocytes could extend survival of Npc1−/− mice over 3-fold (Zhang et al., 2008 [13]). We have now studied expression only in neurons or in both neurons and fibrillary astrocytes. Neuron-only expression resulted in survivals of over a year (>5-fold) but motor symptoms started at about 6 months. As reflected in weight gain, this especially affected females who weighed less than wild-type starting at about 10 weeks while male differences in weight are delayed. Expression in both cell types led to a nearly normal phenotype with motor symptoms developing at about ten months and increased survival times. Purkinje cell loss was slowed, but severe, in both NSE- and NSE-GFAP-Npc1, transgenic Npc1−/− mice. MRI studies showed that myelination of the long tracts was significantly improved in NSE-Npc1 transgenics, perhaps less than in GFAP-Npc1 transgenics, and not differently than in the double transgenics. Memory was improved in both single and double transgenics. Somatic disease had not been ameliorated and lungs were massively infiltrated with foamy macrophages at 10 months. Our results suggest that neuron-only expression does not completely prevent neurodegeneration and that the addition of astrocyte expression decreases the rate/degree of decline.
